Intracellular Accumulation of Human Immunodeficiency Virus Protease Inhibitors
Open Access
- 1 October 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (10) , 3228-3235
- https://doi.org/10.1128/aac.46.10.3228-3235.2002
Abstract
Intracellular accumulation of the protease inhibitors (PIs) saquinavir (SQV), ritonavir (RTV), and indinavir (IDV) was determined in 50 human immunodeficiency virus-positive patients. Following extraction, PIs were quantified by mass spectrometry. Paired plasma and intracellular samples were collected over a full dosing interval from patients (13 on SQV, 6 on RTV, 8 on IDV, 16 on SQV plus RTV, 7 on IDV plus RTV) with a plasma viral load of 1.00 for RTV > 0.51 for IDV. Coadministration of RTV did not boost ratios of SQV or IDV within the cell or in plasma, although absolute plasma and intracellular SQV concentrations were increased by RTV. Seven individuals receiving SQV in hard-gel capsule form (median, 32 months) had higher intracellular/plasma drug ratios than all other patients receiving SQV (median, 17.62 versus 4.83; P = 0.04), despite consistently low plasma SQV concentrations. How this occurs may provide insight into the mechanisms that limit adequate drug penetration into sanctuary sites.Keywords
This publication has 21 references indexed in Scilit:
- Long-term suppression of viral replication despite low plasma saquinavir concentrations in the CHEESE StudyPublished by Wiley ,2002
- Pharmacokinetic Profiles of Nevirapine and Indinavir in Various Fractions of Seminal PlasmaAntimicrobial Agents and Chemotherapy, 2001
- P-glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?AIDS, 2001
- Antiretroviral drug concentrations in semen of HIV-1 infected menSexually Transmitted Infections, 2001
- Pharmacological Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine, and IndinavirAntimicrobial Agents and Chemotherapy, 2001
- Human Immunodeficiency Virus Type 1 Shedding Pattern in Semen Correlates with the Compartmentalization of Viral Quasi Species between Blood and SemenThe Journal of Infectious Diseases, 2000
- Antiretroviral Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Protease from Paired Cerebrospinal Fluid and Plasma SamplesThe Journal of Infectious Diseases, 2000
- Relationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive PatientsClinical Pharmacokinetics, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998